8XZW | pdb_00008xzw

Crystal structure of THF-II riboswitch with THF and soaked with Ir


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.91 Å
  • R-Value Free: 
    0.251 (Depositor), 0.265 (DCC) 
  • R-Value Work: 
    0.215 (Depositor), 0.238 (DCC) 
  • R-Value Observed: 
    0.219 (Depositor) 

Starting Model: experimental
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 8XZW

Ligand Structure Quality Assessment 


This is version 1.1 of the entry. See complete history

Literature

Structure-based characterization and compound identification of the wild-type THF class-II riboswitch.

Li, C.Xu, X.Geng, Z.Zheng, L.Song, Q.Shen, X.Wu, J.Zhao, J.Li, H.He, M.Tai, X.Zhang, L.Ma, J.Dong, Y.Ren, A.

(2024) Nucleic Acids Res 52: 8454-8465

  • DOI: https://doi.org/10.1093/nar/gkae377
  • Primary Citation Related Structures: 
    8XZE, 8XZK, 8XZL, 8XZM, 8XZN, 8XZO, 8XZP, 8XZQ, 8XZR, 8XZW

  • PubMed Abstract: 

    Riboswitches are conserved regulatory RNA elements participating in various metabolic pathways. Recently, a novel RNA motif known as the folE RNA motif was discovered upstream of folE genes. It specifically senses tetrahydrofolate (THF) and is therefore termed THF-II riboswitch. To unravel the ligand recognition mechanism of this newly discovered riboswitch and decipher the underlying principles governing its tertiary folding, we determined both the free-form and bound-form THF-II riboswitch in the wild-type sequences. Combining structural information and isothermal titration calorimetry (ITC) binding assays on structure-based mutants, we successfully elucidated the significant long-range interactions governing the function of THF-II riboswitch and identified additional compounds, including alternative natural metabolites and potential lead compounds for drug discovery, that interact with THF-II riboswitch. Our structural research on the ligand recognition mechanism of the THF-II riboswitch not only paves the way for identification of compounds targeting riboswitches, but also facilitates the exploration of THF analogs in diverse biological contexts or for therapeutic applications.


  • Organizational Affiliation
    • Life Sciences Institute, Second Affiliated Hospital of Zhejiang University School of Medicine, Zhejiang Key Laboratory of Biotherapy, Zhejiang University, Hangzhou 310058, China.

Macromolecule Content 

  • Total Structure Weight: 17.89 kDa 
  • Atom Count: 1,205 
  • Modeled Residue Count: 53 
  • Deposited Residue Count: 53 
  • Unique nucleic acid chains: 1

Macromolecules

Find similar nucleic acids by:  (by identity cutoff) 
Entity ID: 1
MoleculeChains LengthOrganismImage
RNA (53-MER)53unidentified eubacterium clone A70
Sequence Annotations
Expand
Reference Sequence

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.91 Å
  • R-Value Free:  0.251 (Depositor), 0.265 (DCC) 
  • R-Value Work:  0.215 (Depositor), 0.238 (DCC) 
  • R-Value Observed: 0.219 (Depositor) 
Space Group: P 21 21 21
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 49.105α = 90
b = 57.5β = 90
c = 62.185γ = 90
Software Package:
Software NamePurpose
PHENIXrefinement
HKL-3000data scaling
HKL-3000data reduction
PHASERphasing

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

& Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
National Natural Science Foundation of China (NSFC)China--

Revision History  (Full details and data files)

  • Version 1.0: 2024-07-24
    Type: Initial release
  • Version 1.1: 2024-08-21
    Changes: Database references